Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.
Abdel-Aal
Abu-Baker M
AB
School of Chemistry and Molecular Biosciences (SCMB), The University of Queensland, QLD 4072, Queensland, Australia.
Zaman
Mehfuz
M
Fujita
Yoshio
Y
Batzloff
Michael R
MR
Good
Michael F
MF
Toth
Istvan
I
D000281:Administration, Intranasal; D000818:Animals; D018985:Epitopes, B-Lymphocyte; D018984:Epitopes, T-Lymphocyte; D005260:Female; D055666:Lipopeptides / Q000008:administration & dosage / Q000737:chemistry* / Q000276:immunology; D051379:Mice; D017433:Protein Structure, Secondary; D013290:Streptococcal Infections / Q000276:immunology / Q000517:prevention & control; D022541:Streptococcal Vaccines / Q000008:administration & dosage / Q000737:chemistry* / Q000276:immunology; D013297:Streptococcus pyogenes / Q000276:immunology*; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology
D018985:Epitopes, B-Lymphocyte; D018984:Epitopes, T-Lymphocyte; D055666:Lipopeptides; D022541:Streptococcal Vaccines; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic